Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
TRYT, First Half Net Income Decreases by 18%, Apr-Jun Net Income Decreases by 12%
9164 TRYT Inc. 【IFRS】
Earnings ReportTRYT Inc. <9164> [TSE Growth] announced its financial results (based on IFRS) after the market closed on August 8th (15:35). The consolidated net income for the cumulative second quarter of the fiscal year ending December 2025 (January to June) decreased 18.1% from the same period last year to 3.43 billion yen. Progress toward the full-year plan of 3.70 billion yen was 92.7%, below the three-year average of 111.2%.
Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated net income/loss for the July to December period (second half) is expected to turn into a profit of 0.27 billion yen (compared to a loss of 1.27 billion yen in the same period last year).
In the most recent three-month period, from April to June (2Q), the consolidated net income decreased to 4.47 billion yen, a 12.1% decrease compared to the same period last year. The operating profit margin decreased from 36.5% in the same period last year to 33.9%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Jun, 2023 | 29,135 | 6,962 | 6,903 | 4,673 | 46.7 | 97.9 | Aug 10, 2023 | IFRS |
| Jan - Jun, 2024 | 31,958 | 6,695 | 6,135 | 4,190 | 41.9 | 141.8 | Aug 9, 2024 | IFRS |
| Jan - Jun, 2025 | 33,129 | 5,753 | 5,166 | 3,430 | 34.3 | 90.6 | Aug 8, 2025 | IFRS |
| YoY | +3.7% | -14.1% | -15.8% | -18.1% | -18.1% |
First Half Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Jun, 2025 Guidance | ー | ー | ー | ー | - | 0 | Feb 13, 2025 | IFRS |
| Jan - Jun, 2025 Results | 33,129 | 5,753 | 5,166 | 3,430 | 34.3 | 0 | Aug 8, 2025 | IFRS |
| Revision Rate | - | - | - | - | - |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Dec, 2024 | 25,158 | -1,509 | -1,810 | -1,273 | -12.7 | 21 | Feb 13, 2025 | IFRS |
| Jul - Dec, 2025 Guidance | 31,171 | 447 | 534 | 270 | 2.7 | 0 | Aug 8, 2025 | IFRS |
| YoY | +23.9% | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2023 | 52,767 | 7,514 | 7,050 | 4,901 | 49.0 | 0 | Feb 13, 2024 | IFRS |
| Dec, 2024 | 57,116 | 5,186 | 4,325 | 2,917 | 29.2 | 21 | Feb 13, 2025 | IFRS |
| Dec, 2025 Guidance | 64,300 | 6,200 | 5,700 | 3,700 | 37.0 | 0 | Jun 10, 2025 | IFRS |
| YoY | +12.6% | +19.6% | +31.8% | +26.8% | +26.8% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Jun, 2024 | 20,106 | 7,348 | 7,455 | 5,088 | 50.9 | 36.5 | Aug 9, 2024 | IFRS |
| Jul - Sep, 2024 | 12,723 | -288 | -847 | -578 | -5.8 | -2.3 | Nov 14, 2024 | IFRS |
| Oct - Dec, 2024 | 12,435 | -1,221 | -963 | -695 | -7.0 | -9.8 | Feb 13, 2025 | IFRS |
| Jan - Mar, 2025 | 12,827 | -1,120 | -1,589 | -1,041 | -10.4 | -8.7 | May 13, 2025 | IFRS |
| Apr - Jun, 2025 | 20,302 | 6,873 | 6,755 | 4,471 | 44.7 | 33.9 | Aug 8, 2025 | IFRS |
| YoY | +1.0% | -6.5% | -9.4% | -12.1% | -12.1% |
Related Articles
Delta-Fly Pharma, Apr-Jun (1Q) Net Income Loss Narrows
LUCKLAND, Ordinary Profit Forecast for First Half Revised Upward to an Unexpected 27% Increase, Raises Record High Profit, Full Year also Increased
Jimoto Holdings, Apr-Jun (1Q) Ordinary Profit Decreases by 8%, Exceeds First Half Plan
KLASS, Apr-Jun (3Q) Ordinary Profit Turns to Loss
Future Innovation Group, First Half Ordinary Profit Increases by 43%
MS&AD Insurance, Apr-Jun (1Q) Ordinary Profit Decreases by 5%
CHARLE, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 26%
Asia Air Survey, Oct-Jun (Cumulative 3Q) Ordinary Profit Decreases by 21%
JANOME, Apr-Jun (1Q) Ordinary Profit Turns to Loss
Laxus, Apr-Jun (1Q) Ordinary Profit 31 Million Yen